Cent Eur J Public Health 2004, 12(4):201-206

Epidemiology of AIDS Determining Conditions in Greece

Masgala A., Nikolopoulos G., Tsantes A., Paraskeva D.
HIV Infection Office, Hellenic Centre for Infectious Diseases Control, Greece

Objective: To examine the secular trends of all AIDS opportunistic infections to occur first (OIs) in Greece, by year, by gender and by mode of transmission.

Methods: The study included all AIDS defining conditions reported among Greek residents diagnosed with AIDS from 1981 to June 2003 and notified to the Hellenic Centre of Infectious Diseases Control. The analysis of trends in AIDS defining conditions in Greece has been performed only for the period 1993-2003.

Results: From 1981 to the first six months of 2003, 2,394 AIDS cases, 2,361 adults and 33 children, have been reported. HIV wasting syndrome was the most frequent OI to occur first followed by PCP pneumonia and Kaposi sarcoma. The frequency at which OIs occurred first varied by sex. Kaposi sarcoma was more frequent in males while tuberculosis and oesophageal candidiasis were more frequent in females. The frequency at which OIs occurred first varied also by exposure mode. Kaposi sarcoma was more frequent among men who have sex with men but that was not the case for the remaining transmission categories.
From 1993 to the first six months of 2003 a downward trend was noticed only for chronic simplex disease. Since the introduction of HAART, an increasing trend was noticed for CMV disease, recurrent pneumonia, oesophageal candidiasis, Burkitt and immunoblastic lymphoma.

Conclusion: Further epidemiological studies are needed to assess the OIs trends in coming years in order to plan prevention strategies and future medical care needs.

Keywords: AIDS, opportunistic infections, trends

Received: June 30, 2004; Revised: August 18, 2004; Accepted: August 18, 2004; Published: December 1, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Masgala A, Nikolopoulos G, Tsantes A, Paraskeva D. Epidemiology of AIDS Determining Conditions in Greece. Cent Eur J Public Health. 2004;12(4):201-206. PubMed PMID: 15666458.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ancelle-Park RA: Expanded European AIDS case definition. Lancet, 1993; 341: 441. Go to original source...
    2. Half-Yearly Edition of the Hellenic Centre for Infectious Diseases Control (HCIDC)- Ministry of Health and Wellfare.
    3. Blaxhult A, Fox Z, Colebunders R, Francioli P et al: Regional and temporal changes inAIDS in Europe before HAART. Epidemio Infect, 2002 Dec; 129(3): 565-76. Go to original source...
    4. Smit E, Slolasky RL, DobsAS, Calhoun BC et al: Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol, 2002 Aug 1; 156(3): 211-8. Go to original source...
    5. Welch K, Morse A: Adult Spectrum of Disease Project in New Orleans "The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy" AIDS Patient Care STDS, 2002 Feb; 16 (2): 75-81. Go to original source... Go to PubMed...
    6. Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL: Gender differences in reportedAIDS-indicative diagnoses. J Infect Dis, 1993 Jul; 168(1): 61-7. Go to original source... Go to PubMed...
    7. Atzori C, Clerici M, Trabattoni D, Fantoni G, Valerio A, Tronconi E, Cargnel A: Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens. JAntimicrob Chemother, 2003Aug; 52(2): 276-81. Epub 2003 Jul 01. Go to original source... Go to PubMed...
    8. Pulvirenti J, Herrera P, Venkataraman P, Ahmed N: Pneumonocystis carinii pneumonia in HIV-infected patients in the HAART era. AIDS Patient Care STDS, 2003 Jun; 17(6): 261-5. Go to original source... Go to PubMed...
    9. Ljones J, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J: Surveillance for AIDS Defining Opportunistic Illnesses, 1992-1997. MMWR, April 16, 1999/Vol. 48/No. SS-2. Go to original source...
    10. Dore GJ, LiY, McDonaldA, Ree H, Kaldor JM, Kaldo JM: National HIV Surveillance Committee "Impact of highly active antiretroviral therapy on individualAIDS-defining illness incidence and survival inAustralia". J Acquir Immune Defic Syndr, 2002 Apr 1; 29(4): 388-95. Go to original source...
    11. San-Andres FJ, Rubio R, Castilla J, Pulido F, Palao G, de Pedro I, Costa JR, del PalacioA: Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997. Clin Infect Dis, 2003 May 1; 36(9): 1177-85. Go to original source... Go to PubMed...
    12. Eldred LJ, WuAW, Chaisson RE, Moore RD:Adherence to antiretroviral and pneumonocystis prophylaxis in HIV disease. J Acquir Immun Def Syndr Hum Retrovirol, 1998 Jun 1; 18(2): 117-25. Go to original source...
    13. Grulich AE Update: cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy. AIDS Read, 2000 Jun; 10(6): 341-6. Go to PubMed...
    14. Grulich AE, Li Y, McDonald AM, Corrrell PK, Law MG, Kaldor JM: Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS, 2001 Mar 30; 15(5): 629-33. Go to original source... Go to PubMed...
    15. CattelanAM, Trevenzoli M,Aversa SM: Recent advances in the treatment of AIDS-related Kaposi's sarcoma. Am J Clin Dermatol, 2002; 3(7): 451-62. Go to original source... Go to PubMed...
    16. Gates AE, Kaplan LD: AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Huntingt), 2002 Apr; 16(4): 441-51, 456, 459. Go to PubMed...
    17. Sgadari C, Morini P, Barillari G, Ensoli B: Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth. Lancet Oncol, 2003 Sep; 4(9): 537-47. Go to original source...
    18. Nasti G, Martellotta F, Berretta M, Mena M et al: Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer, 2003; 98(11): 2440-6. Go to original source... Go to PubMed...
    19. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ: Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 1999 Jul 9; 13(10): 1249-53. Go to original source... Go to PubMed...
    20. Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W: HIV-related neuropathology, 1985 to 1999: rising prevalence of HIVencephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr, 2002 Oct 1; 31(2): 171-7 Go to original source... Go to PubMed...
    21. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ: National HIV Surveillance Committee "Marked improvement in survival followingAIDS dementia complex in the era of highly active antiretroviral therapy". AIDS, 2003 Jul 4; 17(10): 1539-45. Go to original source... Go to PubMed...
    22. Pezzotti P, Serraino D, Rezza G et al.: The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996. Int J Epidemiol,1999; 28 :975-981. Go to original source...
    23. Kaplan JE, Hanson D, Dworkin MS et al.: Epidmiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis, 2000 Apr; 30 Suppl 1: S5-14. Go to original source... Go to PubMed...
    24. Sudre P, J Hirschel B, Gatell J M et al.: Tuberculosis among European patients with the acquired immune deficiency syndrome. Tubercle Lung Dis, 1996; 77: 322-28. Go to original source...
    25. Kirk O, Gatell J M, Mocroft A et al.: Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of HighlyActiveAntiretroviral Therapy.Am J Resp Crit Care Med, 200; 62: 865-72.
    26. van Asten L, Langendam M, Zangerle R et al.: Tuberculosis risk varies with the duration of HIV infection: a retrospective study of European drug users with known date of HIV seroconversion. AIDS, 2003; 17: 1201-8. Go to original source... Go to PubMed...
    27. Soriano V, Dona C, Rodriguez-Rosado R, Barreiro P, Gonzalez-Lahoz J: Discontinuation of secondary prophylaxis for opportunistic infections in HIV patients receiving highly active antiretroviral therapy. AIDS, 2000 Mar 10; 14(4): 383-6. Go to original source... Go to PubMed...
    28. Schurmann D, Bergmann F, Albrecht H, Padberg J et al.: Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Eur J Clin Microbiol Infect Dis, 2002 May; 21(5): 353-61. Go to original source...
    29. Kirk O, Reiss P, Uberti-Foppa C, Bickel M et al.: Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy". Ann Intern Med, 2002 Aug 20; 137(4): 239-50. Go to original source...
    30. Thirwell C, Sarker D, Stebbing J, Bower M :Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. Clin Lymphoma, 2003 Sep; 4(2): 86-92. Go to original source... Go to PubMed...
    31. Cadman J: Candidiasis in immune-compromised women. GMHC Treat Issues 1997, Jul-Aug; 11(7-8): 18. Go to PubMed...
    32. Nelson KE, Vlahov D, Cohn S et al.: Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). J Infect Dis, 1991; 164:457-63. Go to original source...
    33. Hudelson P: Gender differentials in tuberculosis: the role of socioeconomic and cultural factors. Tuber Lung Dis, 1996 Oct; 77(5): 391-400 Go to original source... Go to PubMed...
    34. Cannon MJ, Laney AS, Pellett PE: Human herpesvirus 8: current issues. Clin Infect Dis, 2003 Jul 1; 37(1): 82-7. Go to original source... Go to PubMed...
    35. Jones JL, Hanson DL, Dworkin MS, Kaplan JE, Ward JW: Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996. J Infect Dis, 1998; 178: 114-20. Go to original source...
    36. Stanková M, Rozsypal H, Kubín M, Šlosarek M, Horová B, Bručková M: Mycobacterial infections in patients withAIDS in a low HIV prevalence area. Cent Eur J Public Health, 1994; 2(2): 100-2.
    37. Jarošiková T, Sow OY, Traore S, Krestanpol M, Kubín M, Bručková M: Detection of serum antibodies in tuberculosis patients. Cent Eur J Publ Health, 1994; 2(1): 60-1.
    38. McNaghtenAD, Hanson L, NakashimaAK, Swerdlow DL: Incidence of AIDS-defining opportunistic infections in the US may be leveling from 1998-1999. Program and abstracts of the Infectious Diseases Society of America; October 25-28, 2001;San Francisco, California, Abstract 751.

    Return to the content